In an interview with journalist Peggy Elfmann, Michaela Butryn explains what the new antibody therapies for Alzheimer’s can achieve, but also where their limitations lie.
Here is the link to the new episode of “Leben. Lieben. Pflegen. The Desideria Podcast on Dementia and Family.”